US2490813A
(en)
|
1944-11-29 |
1949-12-13 |
Standard Oil Co |
Continuous process for making aryl amines
|
US3299078A
(en)
|
1962-10-01 |
1967-01-17 |
Smith Kline French Lab |
Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
|
US3813392A
(en)
|
1969-06-09 |
1974-05-28 |
J Sellstedt |
Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds
|
US4183936A
(en)
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
US3914421A
(en)
|
1972-06-19 |
1975-10-21 |
Endo Lab |
Pyridopyrrolobenzheterocycles for combatting depression
|
US4115577A
(en)
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4001263A
(en)
|
1974-04-01 |
1977-01-04 |
Pfizer Inc. |
5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
|
IE41352B1
(en)
|
1974-04-01 |
1979-12-19 |
Pfizer |
5-aryl-1,2,3,4-tetrahydro- -carbolines
|
US4219550A
(en)
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4522944A
(en)
|
1982-12-23 |
1985-06-11 |
Erba Farmitalia |
Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, compositions and use
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
ATE90683T1
(de)
|
1986-03-19 |
1993-07-15 |
Kumiai Chemical Industry Co |
5h-1,3,4-thiazol(3,2-a>pyrimidin-5-on-derivate und diese enthaltende fungizide zubereitungen.
|
ES2058069T3
(es)
|
1986-04-07 |
1994-11-01 |
Kumiai Chemical Industry Co |
Derivados de 5h-1,3,4-tiadiazolo-(3,2-a)-pirimidin-5-ona y nuevo compuesto fungicida agricola-horticola que contiene dicho derivado.
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
IT1271352B
(it)
|
1993-04-08 |
1997-05-27 |
Boehringer Ingelheim Italia |
Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
|
JP3645906B2
(ja)
|
1993-11-19 |
2005-05-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
マイクロカプセル封入された3−ピペリジニル−置換1,2−ベンズイソオキサゾール類及び1,2−ベンズイソチアゾール類
|
AU707748B2
(en)
|
1994-03-25 |
1999-07-22 |
Isotechnika Inc. |
Enhancement of the efficacy of drugs by deuteration
|
US5576460A
(en)
|
1994-07-27 |
1996-11-19 |
Massachusetts Institute Of Technology |
Preparation of arylamines
|
US5654482A
(en)
|
1996-02-29 |
1997-08-05 |
Xerox Corporation |
Triarylamine processes
|
US5648539A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Low temperature arylamine processes
|
US5648542A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Arylamine processes
|
US5847166A
(en)
|
1996-10-10 |
1998-12-08 |
Massachusetts Institute Of Technology |
Synthesis of aryl ethers
|
US5723669A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
US5723671A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
US5705697A
(en)
|
1997-01-30 |
1998-01-06 |
Xerox Corporation |
Arylamine processes
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
US6323366B1
(en)
|
1997-07-29 |
2001-11-27 |
Massachusetts Institute Of Technology |
Arylamine synthesis
|
GB2328686B
(en)
|
1997-08-25 |
2001-09-26 |
Sankio Chemical Co Ltd |
Method for producing arylamine
|
US6884429B2
(en)
|
1997-09-05 |
2005-04-26 |
Isotechnika International Inc. |
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
|
US6395939B1
(en)
|
1997-10-06 |
2002-05-28 |
Massachusetts Institute Of Technology |
Diaryl ether condensation reactions
|
EP1058678B1
(en)
|
1998-02-26 |
2002-12-11 |
Massachusetts Institute of Technology |
Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
|
US6235936B1
(en)
|
1998-02-26 |
2001-05-22 |
Massachusetts Institute Of Technology |
Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
|
US5902901A
(en)
|
1998-05-07 |
1999-05-11 |
Xerox Corporation |
Arylamine processes
|
US6307087B1
(en)
|
1998-07-10 |
2001-10-23 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
EP1097158B1
(en)
|
1998-07-10 |
2006-01-25 |
Massachusetts Institute Of Technology |
Ligands for metals and metal-catalyzed processes
|
US6395916B1
(en)
|
1998-07-10 |
2002-05-28 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
US7223879B2
(en)
|
1998-07-10 |
2007-05-29 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
US20010008942A1
(en)
|
1998-12-08 |
2001-07-19 |
Buchwald Stephen L. |
Synthesis of aryl ethers
|
MXPA01006108A
(es)
|
1998-12-17 |
2002-09-18 |
Alza Corp |
Conversion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples recubrimientos.
|
ATE400252T1
(de)
*
|
1999-02-10 |
2008-07-15 |
Pfizer Prod Inc |
Pharmazeutische feste dispersionen
|
NO309305B1
(no)
|
1999-02-19 |
2001-01-15 |
Norsk Hydro As |
Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
PE20010052A1
(es)
|
1999-04-23 |
2001-01-27 |
Upjohn Co |
Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
|
MXPA01012969A
(es)
|
1999-06-15 |
2003-10-14 |
Bristol Myers Squibb Pharma Co |
Gamma-carbolinas fusionadas de heterociclo sustituido.
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
US6541639B2
(en)
|
2000-07-26 |
2003-04-01 |
Bristol-Myers Squibb Pharma Company |
Efficient ligand-mediated Ullmann coupling of anilines and azoles
|
PE20020443A1
(es)
|
2000-09-20 |
2002-05-16 |
Upjohn Co |
DERIVADOS AZEPINO [4,5-b] INDOL SUSTITUIDOS COMO LIGANDOS DEL RECEPTOR DE SEROTONINA 5HT
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
HUP0303432A3
(en)
|
2000-12-20 |
2012-09-28 |
Bristol Myers Squibb Co |
Substituted pyridoindoles as serotonin agonists and antagonists and pharmaceutical compositions containing the compounds and their use
|
JP5291854B2
(ja)
|
2001-04-24 |
2013-09-18 |
マサチューセッツ インスチテュート オブ テクノロジー |
炭素−ヘテロ原子間及び炭素−炭素間結合の銅を触媒とした形成
|
DE10123129A1
(de)
|
2001-05-02 |
2002-11-14 |
Berolina Drug Dev Ab Svedala |
Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel
|
ATE444060T1
(de)
*
|
2001-06-22 |
2009-10-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
|
WO2003014118A1
(en)
|
2001-08-08 |
2003-02-20 |
Pharmacia & Upjohn Company |
THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
|
EP1314554A1
(fr)
|
2001-11-23 |
2003-05-28 |
Kba-Giori S.A. |
Dispositif de décollage d'éléments de sécurité
|
DE10162121A1
(de)
|
2001-12-12 |
2003-06-18 |
Berolina Drug Dev Ab Svedala |
Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
DK1539115T3
(da)
|
2002-07-29 |
2008-01-28 |
Alza Corp |
Fremgangsmåder og doseringsformer til kontrolleret levering af paliperidon
|
AU2003257062A1
(en)
|
2002-08-02 |
2004-02-23 |
Massachusetts Institute Of Technology |
Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
AU2003287433A1
(en)
|
2002-11-01 |
2004-06-07 |
Oregon Health And Science University |
Treatment of hyperkinetic movement disorder with donepezil
|
PL377426A1
(pl)
|
2002-12-19 |
2006-02-06 |
Bristol-Myers Squibb Company |
Podstawione tricykliczne gamma-karboliny jako agoniści i antagoniści receptora serotoninowego
|
NZ541146A
(en)
|
2003-01-16 |
2009-04-30 |
Acadia Pharm Inc |
N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide, also known as ACP-103, and its tartrate salt as therapeutics for neurodegenerative diseases
|
RU2006106429A
(ru)
|
2003-07-21 |
2006-08-27 |
СмитКлайн Бичем Корпорейшн (US) |
Соль (2s, 4s)-4-фтор-1-(4-фтор-бета-(4-фторфенил)-l-фенилаланил) -2-пирролидинкарбонитрила с пара-толуолсульфоновой кислоты и ее безводные кристаллические формы
|
SA04250304B1
(ar)
|
2003-09-26 |
2009-03-11 |
سولفاي فارماسوتيكالز بي . في |
مشتقات هكسا - واوكتاهيدرو - بيريدو {1،2-a} بيرازين ذات نشاط مضاد لـ nk1
|
JP2005259113A
(ja)
|
2004-02-12 |
2005-09-22 |
Ricoh Co Ltd |
プロセス編集装置、プロセス管理装置、プロセス編集プログラム、プロセス管理プログラム、記録媒体、プロセス編集方法及びプロセス管理方法
|
CA2564018A1
(en)
|
2004-03-05 |
2005-10-13 |
Pharma C S.A. |
8-phenoxy-.gamma. carboline derivatives
|
US20050222209A1
(en)
|
2004-04-01 |
2005-10-06 |
Zeldis Jerome B |
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
WO2006011610A1
(en)
|
2004-07-26 |
2006-02-02 |
Ricoh Company, Ltd. |
Lens barrel, camera and mobile information terminal
|
ES2367868T3
(es)
|
2004-09-20 |
2011-11-10 |
Mount Sinai School Of Medicine |
Uso de memantina (namenda) para tratar el autismo, la compulsividad y la impulsividad.
|
WO2006032999A1
(en)
|
2004-09-21 |
2006-03-30 |
Pfizer Products Inc. |
N-methyl hydroxyethylamine useful in treating cns conditions
|
US7614727B2
(en)
|
2004-09-30 |
2009-11-10 |
Fujifilm Corporation |
Liquid ejection head, manufacturing method thereof, and image forming apparatus
|
ATE457989T1
(de)
|
2004-12-15 |
2010-03-15 |
Hoffmann La Roche |
Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
|
CA2595711A1
(en)
|
2005-01-25 |
2006-08-03 |
Celgene Corporation |
Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
|
US7968538B2
(en)
|
2005-01-25 |
2011-06-28 |
Galenea Corp. |
Substituted arylamine compounds and methods of treatment
|
EP1919287A4
(en)
|
2005-08-23 |
2010-04-28 |
Intra Cellular Therapies Inc |
ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR SIGNALING ACTIVITY
|
BRPI0617987A2
(pt)
|
2005-10-06 |
2011-08-16 |
Auspex Pharmaceuticals Inc |
composição, composição farmacêutica, forma de dosagem efervescente, composição farmacêutica oral de comprimidos unitários múltiplos, forma de dosagem farmacêutica de liberação prolongada, forma de dosagem farmacêutica revestida entérica, forma de dosagem farmacêutica estável para administração oral a sujeitos mamìferos, método para tratamento de doenças relacionadas a ácido gástrico pela inibição de secreção de ácido gástrico, método para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori, processo para preparar um composto da fórmula 3, processo para preparar um composto da fórmula 5, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relacionadas a ácido gástrico, pela inibição de secreção de ácido gástrico, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relecionadas a ácido gástrico pela inibição de secreção de ácido gástrico
|
KR20080114688A
(ko)
|
2006-01-13 |
2008-12-31 |
와이어쓰 |
5-히드록시트립타민 수용체에 대한 리간드로서의 술포닐 치환된 1h-인돌
|
US7750168B2
(en)
|
2006-02-10 |
2010-07-06 |
Sigma-Aldrich Co. |
Stabilized deuteroborane-tetrahydrofuran complex
|
BRPI0716604A2
(pt)
|
2006-09-08 |
2013-04-09 |
Braincells Inc |
combinaÇÕes contendo um derivado de 4-acilaminopiridina
|
CN103626766B
(zh)
|
2007-03-12 |
2017-06-09 |
细胞内治疗公司 |
与取代的杂环稠合的γ‑咔啉的合成
|
US7612447B2
(en)
|
2007-06-06 |
2009-11-03 |
Gm Global Technology Operations, Inc. |
Semiconductor devices with layers having extended perimeters for improved cooling and methods for cooling semiconductor devices
|
KR20100054812A
(ko)
*
|
2007-08-01 |
2010-05-25 |
메디베이션 뉴롤로지 인코퍼레이티드 |
항정신병제 조합 치료제를 사용하여 정신분열증을 치료하기 위한 방법 및 조성물
|
WO2009023253A2
(en)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
|
US20090209608A1
(en)
|
2007-08-29 |
2009-08-20 |
Protia, Llc |
Deuterium-enriched asenapine
|
US20090076159A1
(en)
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eplivanserin
|
CN101983058A
(zh)
|
2008-02-05 |
2011-03-02 |
克莱拉有限公司 |
缓解抑郁症或改善认知的组合物和方法
|
US8475793B2
(en)
|
2008-02-07 |
2013-07-02 |
Merck Sharp & Dohme Corp. |
Engineered anti-TSLPR antibodies
|
US8648077B2
(en)
*
|
2008-03-12 |
2014-02-11 |
Intra-Cellular Therapies, Inc. |
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals
|
US8598119B2
(en)
|
2008-05-27 |
2013-12-03 |
Intra-Cellular Therapies, Inc. |
Methods and compositions for sleep disorders and other disorders
|
ES2660962T3
(es)
*
|
2008-07-28 |
2018-03-26 |
Takeda Pharmaceutical Company Limited |
Composición farmacéutica fotoestabilizada
|
US8309772B2
(en)
|
2008-07-31 |
2012-11-13 |
Celanese International Corporation |
Tunable catalyst gas phase hydrogenation of carboxylic acids
|
US20100159033A1
(en)
|
2008-09-29 |
2010-06-24 |
Auspex Pharmaceuticals, Inc. |
Benzisoxazole modulators of d2 receptor, and/or 5-ht2a receptor
|
US20100297194A1
(en)
*
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
US8993572B2
(en)
|
2010-04-22 |
2015-03-31 |
Intra-Cellular Therapies, Inc. |
Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
|
CN103476372B
(zh)
|
2010-12-16 |
2016-04-27 |
Cynapsus疗法有限公司 |
舌下薄膜
|
DE102011014184A1
(de)
|
2011-03-16 |
2012-09-20 |
Khs Gmbh |
Vorrichtung und Verfahren zur Stabilisierung einer Flüssigkeit, insbesondere Bier
|
US8420057B2
(en)
|
2011-09-01 |
2013-04-16 |
Qualicaps, Inc. |
Capsule having broad color spectrum
|
WO2013106433A1
(en)
*
|
2012-01-09 |
2013-07-18 |
Virginia Tech Intellectual Properties, Inc. |
Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs
|
EP2836213B1
(en)
|
2012-04-14 |
2018-07-04 |
Intra-Cellular Therapies, Inc. |
Fused gamma carbolines
|
UA116216C2
(uk)
|
2012-09-14 |
2018-02-26 |
Еббві Дойчланд Гмбх Унд Ко. Кг |
Трициклічні хінолінові і хіноксалінові похідні
|
JP2014074145A
(ja)
*
|
2012-10-05 |
2014-04-24 |
Olympus Corp |
セルロースナノファイバーとその製造方法、複合樹脂組成物、成形体
|
EP2968320B1
(en)
|
2013-03-15 |
2020-11-11 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2015035128A1
(en)
|
2013-09-06 |
2015-03-12 |
Vaxin Inc. |
Methods and compositions for viral vectored vaccines
|
BR112016006182B1
(pt)
*
|
2013-09-30 |
2023-01-10 |
Zoetis Services Llc |
Composição veterinária de longa duração e seus usos
|
KR102373288B1
(ko)
|
2013-12-03 |
2022-03-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
RU2728787C2
(ru)
|
2014-04-04 |
2020-07-31 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
JP2017509677A
(ja)
|
2014-04-04 |
2017-04-06 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
有機化合物
|
US10179776B2
(en)
|
2014-06-09 |
2019-01-15 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
EP3302442B1
(en)
|
2015-06-03 |
2024-10-16 |
Triastek, Inc. |
Dosage forms and use thereof
|
PT3838274T
(pt)
|
2016-01-26 |
2023-12-18 |
Intra Cellular Therapies Inc |
Derivado de pirido[3',4':4,5]pirrolo[1,2,3-de]quinoxalina para utilização no tratamento de distúrbios do snc
|
WO2017165843A1
(en)
|
2016-03-25 |
2017-09-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US20200392135A1
(en)
|
2016-03-25 |
2020-12-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2017172811A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel co-crystals
|
HRP20211666T1
(hr)
|
2016-08-09 |
2022-02-18 |
Teva Pharmaceuticals International Gmbh |
Oblici soli lumateperon ditozilata u krutom stanju
|
US20180092864A1
(en)
|
2016-09-30 |
2018-04-05 |
Zogenix International Limited |
Compositions and methods for treating seizure disorders
|
WO2018071233A1
(en)
|
2016-10-12 |
2018-04-19 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
WO2018106916A1
(en)
|
2016-12-07 |
2018-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated quinoxaline compounds
|
US11292793B2
(en)
|
2017-04-10 |
2022-04-05 |
Dr. Reddy's Laboratories Limited |
Solid dispersions of amorphous Lumateperone p-Tosylate
|
EP3658145A4
(en)
|
2017-07-26 |
2021-04-21 |
Intra-Cellular Therapies, Inc. |
ORGANIC COMPOUNDS
|
EP3717484A4
(en)
|
2017-11-27 |
2021-08-04 |
Egis Gyógyszergyár Zrt. |
PROCESS FOR THE PRODUCTION OF LUMATEPERON AND ITS SALT
|
EP3765021A4
(en)
|
2018-03-16 |
2022-03-09 |
Intra-Cellular Therapies, Inc. |
NOVEL PROCESSES
|
EP3628007B1
(en)
|
2018-06-06 |
2023-05-03 |
Intra-Cellular Therapies, Inc. |
Novel salts and crystals
|
CA3240552A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
AU2019331490A1
(en)
|
2018-08-31 |
2021-03-18 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
WO2020047407A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|